AA, M., R, T., Z, D., P, H., Y, L., SB, W., . . . AM, K. (2026). Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder. European urology, 89(2), 151. https://doi.org/10.1016/j.eururo.2025.09.4137
Chicago Style (17th ed.) CitationAA, Myers, et al. "Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder." European Urology 89, no. 2 (2026): 151. https://doi.org/10.1016/j.eururo.2025.09.4137.
MLA (9th ed.) CitationAA, Myers, et al. "Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder." European Urology, vol. 89, no. 2, 2026, p. 151, https://doi.org/10.1016/j.eururo.2025.09.4137.